EVERYONE DESERVES TO BE WELL

ARG is an oncology, immunology, rare and neurodegenerative disease-focused contract research organization that provides comprehensive trial management

THERAPEUTIC AREAS

SERVICES

Clinical
Operations

We Take On Partner Study Goals as our Goals

Medical Monitoring

From Start-up, We Act as an Extension of the Sponsor

Data
Management

We Set Expectations, Track Timelines And Measure Quality

Biostatistics

We Deliver Top Products and Services to our Clients

Drug
Safety

We Alleviate the Burden of Study Safety Reporting

Quality
Assurance

We Identify Challenges and Resolve Them Before Critical Stage

Systems Integration

Agility Allows Us to Ask Questions Tailored to Each Study

News & Highlights

Distinguished Researchers, Clinicians Join Atlantic Research Group in Advisory Roles

November 10, 2020

Drs. Schnipper, Stein and Genge Lead New Scientific Advisory Board CHARLOTTESVILLE, Va., Nov. 10, 2020 — Atlantic Research Group (ARG), a global full-service contract research organization, named three leading scientists

Key Takeaways From Global Genes 2020 from Mike Baker and Erin Farris

October 2, 2020

Atlantic Research Group’s Senior Vice-President of Business Development Mike Baker and Vice-President of Operations Erin Farris attended the 2020 Global Genes Live conference. The Patient Advocacy “(un)Summit” held virtually between

Atlantic Research Group Names Mike Enright Chief Financial Officer

August 17, 2020

CHARLOTTESVILLE, Va., August 17, 2020 — Atlantic Research Group (ARG), a global full-service contract research organization (CRO), has announced the hire of Mike Enright, as Chief Financial Officer. The addition